Metraipolis › archive › dc_8b3ec7cb8596

One-Month Rifapentine-Isoniazid Regimen Versus Six-Month Isoniazid Monotherapy for Latent Tuberculosis: Experience from a Reference Center — Europe PMC PMID:41901623

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41901623
DOI
10.3390/medicina62030542
License (as archived)
solo-consultazione
Archived
2026-11-04T18:32:43.372Z
SHA-256 of the archived text
9c9cb2e5018ee2cd8ac10bb6b1f8da9637390153d0b9267010a2717e78f91fa6
Stable URL of this page
https://metraipolis.com/documento/dc_8b3ec7cb8596

How to cite

One-Month Rifapentine-Isoniazid Regimen Versus Six-Month Isoniazid Monotherapy for Latent Tuberculosis: Experience from a Reference Center — Europe PMC PMID:41901623 — Europe PMC (en), https://europepmc.org/article/MED/41901623 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b3ec7cb8596 (Metraipolis archive dc_8b3ec7cb8596, sha256 9c9cb2e5018ee2cd8ac10bb6b1f8da9637390153d0b9267010a2717e78f91fa6)
BibTeX
@misc{dc8b3ec7cb8596,
  title = {One-Month Rifapentine-Isoniazid Regimen Versus Six-Month Isoniazid Monotherapy for Latent Tuberculosis: Experience from a Reference Center — Europe PMC PMID:41901623},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41901623},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b3ec7cb8596; sha256 9c9cb2e5018ee2cd8ac10bb6b1f8da9637390153d0b9267010a2717e78f91fa6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41901623. Agents can read the archived copy with the MCP tool read_document.